Member Info for bignose58

Pom. Thanks for your insight.... typo error..... lol

Or is the 32m figure total patients before Fortacin market penetration % is taken account of. Then our share is approx. 3.9mill for a 1 can / patient at say 60USD = Market pen 1.68%. Seem very very concervative figures....

Pom Maybe you can clarify. According to the said presentaion the 232m European sales is split between an estimated 32m patients. Thats 6USD/patient, which doesn't add up to even 1 can purchased by each patient....or does a family purchase a can and share.... :-) For the States: Sales of 1.132bill USD split between 27m patients = 41USD (seems reasonable if only one can is purchased a year. What am I missing here re the European sales/can ratio figure?

Looks like more "Golden Digit" sells today. Seems some investors are losing interest................ I wonder when we will get the announcement about the 4mill euros........and EYR's are expected in a week or two....will JG add any positive news before or within the results ?

The only answer is JG is totally out of his depth when it comes to investor relations. I would have expected an announcement today to inform the market that the E5 have now been launched (they may not since we have had no conformation) and to state that the total 5 country 4mill milestone payment has been triggered. Also, why not let the market know about the ISSE in Portugal where all the top boys are and where our CSO is giving presentations on our product. It�s easily done, but he chooses not to. Or more likely just doesn�t know how to.

Well someone sold 4m shares in 3 separate deals all at the same time. Mr "Golden Digit" pulling a finger out of the pie ..... ;-)

Yes, agree I probably was being far toooo ambitious expecting a possible return...... a nice thought though ;-) Of course this all does beg the question that now Fortacin has been launched, what are the guys n girls at plethora doing with all this spare time ? They all cannot surely be working on the FDA approval. Most of them are lab-rats, so doesn't that mean they are indeed working on something else or are they still trying to develop a working 6 dose canister.......probably not.

You mean like the Dia*******ly Boot Company....lol

It will be interesting to see if tomorrows event registers with HK. As mentioned, Dr Mike will be there giving a couple of presentations. Also, if anyone is interested and wants to discuss related matters with him (A good opportunity for our long-term resident troll to have another face to face meeting to tell Dr Mike how he should do his job....if he has the balls). Dr Mike will be at the Master Investor on the 17th March in London from 10:00 to 14:00. RPG/PLE have an exhibit/booth there. I'm sure Jim will be there shouting the praises of JG and mentioning those two words again "Money Tree" ;-)

Only one who has never used it, yet complains about it and still posts on this BB...... LOL

I also wonder that since we have had the EU announcement whether we will get launch updates as and when they happen. I'm sure we will be notified once we receive the 4mill euros, although I have no idea if this will be paid as a lump sum or paid in stages to be in line with launch dates, although this so far doesn't appear to have happened since we should have received notification of payments for at least Italy by now. My guess is we will receive a lump sum in about 1 to 2 weeks from tomorrow. I wonder if we will receive an update on Friday to say all the E5 have now been launched and the 4mill Euro payment has been triggered ? I also wonder if we can expect any of that back or will it all be ploughed into the USA approval process and or their bonuses not to mention the Diabolical Boot Company. We will have received 8mill Euros plus the 4.93mill USD last April so I'm sure there are a few million that could be returned to shareholders as a Divi teaser of things to come. It could even provide the SP with a boost........Any one else have any thoughts on this ?

Priority is Europe first and apart from the E5 and the additional 5 we know about (not sure if the 2nd group of 5 will be launched in order as listed), we have no idea in what order the remaining countries will be launched, although I would think either by population or by some market awareness which Recordati has a better understanding of. For example the Netherlands, I'm sure, would be quite highly prioritised since they embrace anything sexual or drug related with open arms ........ and legs....LOL

I did get a response re Ireland. Apparently Recordati decided to move it further down their priority list since they don't consider it important enough. I guess this is due to numbers involved. Strange that this was not considered in the first place, although it may have only been included in the first place due to its proximity to the UK.

It would appear the SP is being kept at 0.38 at the moment, even though there are more sells than buys. :-)

Although I do understand North Africa is at the bottom of the list and Ireland is a small potato in the bigger picture of things, I just want some clarification since its totally unnecessary for any vagueness which shareholders have occasionally been subjected to over the years. Mind you, these questions probably help Jamie to now have a much better understanding of the agreement himself....LOL

Below is the response I received from top management...LOL North Africa is not top on the list for Recordati to launch Fortacin in. They are focused on Europe and the countries where they have sales force in that can target the GPs and Urologists. N Africa for Recordati means Algeria and Tunisia where they have a subsidiary in and Egypt, Morocco and Libya where they have an affiliate in. So it does indeed mean the 5 countries I listed and not selected as per the RPG announcement (depending on what is considered as North Africa although Wiki considers them as I have written). I'm still waiting to hear what happened to dear old Ireland.

So. According to the Recordati website they specify North Africa, which from what I understand includes Egypt, Algeria, Morocco, Tunisia and Libya, yet. In the latest RPG announcement re the European launch they specify "select countries of North Africa" which would indicate to me only some of the above. Obviously the Recordati information is more likely to be correct and will comprise the 5 countries with no exclusions. Any other poster here think otherwise ?

And for the illiterate types Dogs Rollocks...... lol

Whatever way one looks at it, It can be summerised using just 2 words. Huge Potential...... :-)

Based on population figures extracted from the worldometers website, I get approx population for the E5 to be 265.5mill Assuming 50% are men = 132.75mill and assuming 25 % of these are sufferers = 33.2mill and an av price of 50 Euros a can = over 1.6billion euros.........wow as much as that. Anyway, given that Recordati's pessimistic sales figure for the E5 is 20 mill euros (pls correct me if I'm wrong). that means they have assumed a market penetration (including for the "no shows") of about 1.2% !!! Since there is only one other European approved medication, which is nowhere near as friendly to the "Johnson", surely this figure must be higher. Even at just 5%, thats over 80 mill euros, which RPG receives an initial % of around the mid 20's. Seems there is a lot of upward scope for our product even with the multiple drawbacks being put forward...such as men with one leg, men with one eye, men who cant hop, men who keep falling over...etc etc..... LOL You can make your own minds up on what reduction figures you want to use, but it seems to me that currently Recordati's figures are understandably very pessimistic indeed. They cannot be seen to be too optimistic for a new drug. However, I know they are very excited about the product, which would indicate internally they are otherwise very confident. As written by many other posters, it all comes down to whether their excitement will be supported by their marketing, which, so far, from what I have seen, would appear so.... :-) And remember there is still the UK and another 5 countiries to be launched in the second half of this year which will add another 75.7million men. And remember the above is all for the purchase of only 1 can. What hppens if the product is liked and 2 cans or even 3 cans/year are purchased !!!